---
title: "Xinbang Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 107 million yuan, a decrease of 6.69%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255176395.md"
description: "According to the Zhitong Finance APP, Xinbang Pharmaceutical released its semi-annual report for 2025, reporting an operating income of 2.845 billion yuan, a year-on-year decrease of 6.62%. The net profit attributable to shareholders of the listed company was 107 million yuan, a year-on-year decrease of 6.69%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 107 million yuan, a year-on-year decrease of 7.16%. The basic earnings per share were 0.0565 yuan"
datetime: "2025-08-29T10:30:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255176395.md)
  - [en](https://longbridge.com/en/news/255176395.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255176395.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/255176395.md) | [繁體中文](https://longbridge.com/zh-HK/news/255176395.md)


# Xinbang Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 107 million yuan, a decrease of 6.69%

According to the Zhitong Finance APP, Xinbang Pharmaceutical (002390.SZ) released its semi-annual report for 2025, reporting an operating income of 2.845 billion yuan, a year-on-year decrease of 6.62%. The net profit attributable to shareholders of the listed company was 107 million yuan, a year-on-year decrease of 6.69%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 107 million yuan, a year-on-year decrease of 7.16%. The basic earnings per share were 0.0565 yuan

### Related Stocks

- [xinbang phar. (002390.CN)](https://longbridge.com/en/quote/002390.CN.md)